Healthline

Kcentra and Cost: What You Need to Know

Kcentra (prothrombin complex concentrate) is prescribed to treat specific blood clotting problems. It’s usually given in a hospital in emergency situations. Kcentra’s cost may depend on dosage, ...
Medindia

Kcentra®, from CSL Behring, Receives FDA Approval for Use in Warfarin Reversal in Patients Undergoing Surgery

CSL Behring today announced that Kcentra ® (Prothrombin Complex Concentrate [Human]) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication -- urgent reversal of ...
Monthly Prescribing Reference

Kcentra Approved for Urgent Reversal of Warfarin in Emergency Surgery Setting

KCENTRA (prothrombin complex concentrate [human]) 500 Units The FDA has approved the expanded indication for Kcentra (Prothrombin Complex Concentrate [Human]; CSL Behring) to include the urgent ...
UPI

Kcentra approved for the urgent reversal of vitamin K

WASHINGTON, April 30 (UPI) -- The U.S. Food and Drug Administration approved Kcentra for the urgent reversal of vitamin K antagonist anti-coagulation in adults with acute major bleeding. "The FDA's ...
Medindia

The Lancet Publishes CSL Behring's Kcentra Phase III Data

KING OF PRUSSIA, Pa., March 17, 2015 /PRNewswire/ -- CSL Behring today announced that The Lancet has published results from a Phase III clinical study showing Kcentra (Prothrombin Complex Concentrate ...
Forbes

Anticoagulation Update: New Agent For Urgent Anticoagulation Reversal, Pradaxa Label Revised

Here are two small but important changes in the anticoagulation field: FDA approves new product for urgent reversal of anticoagulation. The FDA yesterday approved Kcentra (Prothrombin Complex ...
Medscape

FDA Okays Kcentra to Reverse Anticoagulation, Stop Bleeding

The US Food and Drug Administration (FDA) today approved a plasma-derived product for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding, the agency ...
RAPS

Warfarin Patients Stand to Benefit from New FDA-Approved Drug Kcentra, Company Says

The US Food and Drug Administration (FDA) has approved Kcentra (prothrombin complex concentrate), a new biological treatment indicated for the urgent reversal of vitamin K antagonist (VKA), a class of ...
PharmTech

Phase III Results Show Balfaxar Non-Inferior to Kcentra in Reversing Warfarin Therapy

The 94.3% efficacy of the Octapharma product was just a shade ahead of the 94.2% measured in a comparative product, Kcentra. Results of a Phase III study (LEX-209) of the safety and efficacy of ...
Monthly Prescribing Reference

Certain Lots of Kcentra Recalled Due to Potential Risk of Vial Breakage

The recall notification is due to a potential risk of breakage of the glass vials during transport because of a change in the secondary packaging configuration. CSL Behring is recalling certain lots ...
Motley Fool Australia

CSL Limited results presentation: Hizentra, Kcentra and buying back shares

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...